Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 138,959,875
- Total 13F value
- $1,408,301,843
- Share change
- +6,384,838
- Put/Call ratio
- 52%
- SEC-reported price per share
- $10.13
- Number of holders
- 198
- Value change
- +$64,970,441
- Number of buys
- 107
- Number of sells
- 76
- Shares outstanding
- 305,667,944
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
198
Top holders
10
ABCL full security history
Ownership snapshot
Full 13F holder table
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAILLIE GIFFORD & CO
Disclosed value leader
BAILLIE GIFFORD & CO
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
Lead comparable stake: 4.4%
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO leads the comparable SEC ownership view at 4.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Comparable ownership
Top 5
BAILLIE GIFFORD & CO
4.4%
BlackRock Finance, Inc.
4.1%
VOYA INVESTMENT MANAGEMENT LLC
3.5%
BAKER BROS. ADVISORS LP
3.4%
Capital World Investors
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
Company
|
4.4%
|
$132,109,000
13,357,668 shares
|
— | 30 Sep 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.1%
|
$124,310,000
12,569,140 shares
|
— | 30 Sep 2022 |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
Company
|
3.5%
|
$106,590,435
10,777,597 shares
|
— | 30 Sep 2022 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
3.4%
|
$103,352,000
10,450,180 shares
|
— | 30 Sep 2022 |
| Capital World Investors |
13F
Company
|
3.1%
|
$94,754,000
9,580,759 shares
|
— | 30 Sep 2022 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.4%
|
$41,348,000
4,180,768 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
198
Shares
138,959,875
Rows available
198
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
185
Q4 2022 holders
198
Holder diff
13
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|